Actemra Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Low-Dose Dobutamine and Single-Dose Tocilizumab in Acute Myocardial Infarction With High Risk of Cardiogenic Shock
Conditions:   Acute Myocardial Infarction;   Cardiogenic Shock Interventions:   Drug: Tocilizumab;   Drug: Dobutamine;   Drug: NaCl 0.9% Sponsors:   Rigshospitalet, Denmark;   Novo Nordisk A/S;   Simon Spies Fonden;   Helge Peetz og Verner Peetz og hustru Vilma Peetz Legat Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2022 Category: Research Source Type: clinical trials